ES2662571T3 - Métodos de evaluación de la receptividad endometrial de una paciente tras una hiperestimulación ovárica controlada - Google Patents

Métodos de evaluación de la receptividad endometrial de una paciente tras una hiperestimulación ovárica controlada Download PDF

Info

Publication number
ES2662571T3
ES2662571T3 ES12775259.0T ES12775259T ES2662571T3 ES 2662571 T3 ES2662571 T3 ES 2662571T3 ES 12775259 T ES12775259 T ES 12775259T ES 2662571 T3 ES2662571 T3 ES 2662571T3
Authority
ES
Spain
Prior art keywords
patient
methods
ovarian hyperstimulation
controlled ovarian
endometrial receptivity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12775259.0T
Other languages
English (en)
Inventor
Samir Hamamah
Delphine Haouzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Centre Hospitalier Universitaire de Montpellier
Universite de Montpellier
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Centre Hospitalier Universitaire de Montpellier
Universite de Montpellier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM, Centre Hospitalier Universitaire de Montpellier, Universite de Montpellier filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Application granted granted Critical
Publication of ES2662571T3 publication Critical patent/ES2662571T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2565/00—Nucleic acid analysis characterised by mode or means of detection
    • C12Q2565/50—Detection characterised by immobilisation to a surface
    • C12Q2565/513—Detection characterised by immobilisation to a surface characterised by the pattern of the arrayed oligonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Un método de evaluación de la receptividad endometrial de una paciente tras una hiperestimulación ovárica controlada, que comprende una etapa que consiste en medir el nivel de expresión de quince genes en una muestra de biopsia endometrial obtenida a partir de dicha paciente en el que dichos genes son FGFBP1, MUC20, TMPRSS3, PRUNE2, HES2, MGST1, ERRFI1, EDN1, SLC17A7, MET, CPT1B, DCDC2, LRRC39, IL18RAP y FOXP1.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8

Claims (1)

  1. imagen1
ES12775259.0T 2011-10-21 2012-10-22 Métodos de evaluación de la receptividad endometrial de una paciente tras una hiperestimulación ovárica controlada Active ES2662571T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11306364 2011-10-21
EP11306364 2011-10-21
PCT/EP2012/070892 WO2013057316A2 (en) 2011-10-21 2012-10-22 Methods for assessing endometrial receptivity of a patient after controlled ovarian hyperstimulation

Publications (1)

Publication Number Publication Date
ES2662571T3 true ES2662571T3 (es) 2018-04-09

Family

ID=47046623

Family Applications (1)

Application Number Title Priority Date Filing Date
ES12775259.0T Active ES2662571T3 (es) 2011-10-21 2012-10-22 Métodos de evaluación de la receptividad endometrial de una paciente tras una hiperestimulación ovárica controlada

Country Status (6)

Country Link
US (1) US9453259B2 (es)
EP (1) EP2768976B1 (es)
JP (2) JP6204919B2 (es)
ES (1) ES2662571T3 (es)
PT (1) PT2768976T (es)
WO (1) WO2013057316A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010010201A1 (es) 2008-07-22 2010-01-28 Equipo Ivi Investigacion Sl Perfil de expresion genetica como marcador de la receptividad endometrial
US11129851B2 (en) 2014-06-17 2021-09-28 Igenomix S.L. Stem cell therapy in endometrial pathologies
CN109735627B (zh) * 2019-02-25 2022-04-19 吉林大学 Btbd9基因作为牛超数排卵性状分子标记的应用
CN110042156B (zh) 2019-04-22 2021-12-28 苏州亿康医学检验有限公司 一种判断子宫内膜容受性的方法及其应用

Also Published As

Publication number Publication date
WO2013057316A3 (en) 2013-06-06
US9453259B2 (en) 2016-09-27
PT2768976T (pt) 2018-04-05
WO2013057316A2 (en) 2013-04-25
JP6204919B2 (ja) 2017-09-27
EP2768976A2 (en) 2014-08-27
US20140371092A1 (en) 2014-12-18
JP2014530617A (ja) 2014-11-20
EP2768976B1 (en) 2018-01-10
JP2017184748A (ja) 2017-10-12

Similar Documents

Publication Publication Date Title
ES2484142T3 (es) Diagnóstico molecular y clasificación del melanoma maligno
ES2656962T3 (es) Métodos para evaluar la receptividad del endometrio de una paciente
GB2556004A (en) Markers of stroke and stroke severity
EP3179393A3 (en) Gene expression profile algorithm and test for determining prognosis of prostate cancer
MX380165B (es) Dispositivo integrado de fuente-pixel activo para el analisis rapido de especimenes biologicos y quimicos.
EP3988668A3 (en) Kit or device for detecting early stage pancreatic cancer or pancreatic cancer precursor lesions and detection method therefor
EP4491741A3 (en) Compositions and methods for analyte detection
MX2017003790A (es) Detección de secuencias diana por percepción de nanoporos de sondas sintéticas.
EP2610621A3 (en) Blood cell analyzer, blood cell analyzing method, and non-transitory storage medium
MX2015016047A (es) Metodo y sistema para mantener o mejorar el bienestar.
CL2011002228A1 (es) Aparato para el analisis integrado de acidos nucleicos en tiempo real, y metodo de detecicion de dichas moleculas.
EP3101407A4 (en) Protectant for electron microscope observation of hydrated biological sample, kit for electron microscope observation, method for observation, diagnosis, evaluation, or quantification by electron microscope, and sample stage
MX2014004860A (es) Biomarcadores de cancer de pulmon y usos de los mismos.
BR112014026440A2 (pt) assays, methods and apparatus for assessing rna disruption
ES2662571T3 (es) Métodos de evaluación de la receptividad endometrial de una paciente tras una hiperestimulación ovárica controlada
MA52952A (fr) Méthode de détection permettant la détection d'un analyte dans un échantillon
EP2610813A3 (en) Biomarker evaluation through image analysis
MX380642B (es) Ceramidas y su uso en el diagnostico de enfermedad cardiovascular (ecv).
WO2014130970A3 (en) Optical systems and methods for biological analysis
MX376300B (es) Detección de factores de virulencia microbiana bucal.
WO2017050939A3 (en) Method and array for diagnosing pancreatic cancer in an individual
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
MX2016001719A (es) Metodos y equipos para predecir el riesgo de tener una enfermedad o evento cardiovascular.
TR201819546T4 (tr) Numune tür kökeni için tespit yöntemleri.
GB201014837D0 (en) Biomarker signatures and uses thereof